NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its second quarter revenues increased 3 percent year over year, due in part to its January acquisition of AbD Serotec.

The Hercules, Calif.-based firm brought in total revenues of $525.3 million for the three months ended June 30, compared to $$510.4 million for the second quarter of 2012. It fell short of the consensus Wall Street estimate of $532.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.